Cic edizioni internazionali
Clinical Cases in mineral and bone metabolism

The use of cholecalciferol in patients with hip fracture

Original Article, 48 - 53
doi: 10.11138/ccmbm/2017.14.1.048
Tag this article
Abstract
Enhanced HTML Full text PDF
Introduction. Major osteoporotic fractures are steadily increasing due to population aging. Programs of secondary prevention against refracture are essential to decrease morbidity and mortality and the cost for individuals and the society. Vitamin D supplementation and optimization of calcium intake are of a pivotal importance to start specific osteoporosis treatment and for its safety and efficacy. Cholecalciferol is the most widely employed drug for vitamin D supplementation,
Purpose. Aim of this study was to assess the trends in the use of vitamin D supplements containing cholecalciferol in the population of hip fracture patients older than 65 years, resident in the region of Tuscany (Italy) in the years 2011-2015 and to describe vitamin D status in a subgroup of this individuals directly referred to a bone clinic for further evaluation after hip osteoporotic fracture.
Methods. Data were retrieved from the electronic anonymous regional administrative database administered by the Region of Tuscany (Italy) in the years 2011-2015 within the T.A.R.Ge.T. project (Trattamento Appropriato delle Rifratture Geriatriche in Toscana, i.e., “Appropriate treatment of geriatric refractures in Tuscany”), a program endorsed by the region itself. Data pertaining to cholecalciferol prescriptions and hospital discharge codes were retrieved and appropriately crossed to get data on the use of cholecalciferol supplements in patients before and after a hip fracture.
A retrospective analysis was carried out in a subgroup of subjects (n 254) appropriately referred to the local fracture liaison service after the major osteoporotic fracture and vitamin D status in terms of serum 25(OH) vitamin D levels was assessed.
Results. The majority of subjects experiencing a hip fracture (98.2% and 88.3% in 2011 and 2015, respectively) did not receive vitamin D supplements at the time of the fracture event. Although a trend in increase in prescriptions for cholecalciferol supplements could be observed in the years of the study, the percentage of treated individuals remained low even after the fracture, since only 30-35% of subjects receives cholecalciferol supplements at one year after the fracture. Cholecalciferol remained the most prescribed drug in this population, while a substantial decrease of cholecalciferol in association with calcium salts was observed. The use of high doses of cholecalciferol has decreased in this population, while diminished the use of the drops has been accompanied by an increase in prescriptions of single monthly dose supplements.
Conclusions. The correction of vitamin D inadequacy is preliminary to any treatment for osteoporosis and together with calcium may reduce fracture risk by itself.
The prescription of vitamin D supplements is low in patients before and after a hip fracture in a Mediterranean region and despite the overall increase in vitamin use and abuse in the general population. Proper educational programs and active fracture liaison services are needed in order to bridge this gap.

Vol. XIV (No. 2) 2017 May - August

  1. From the Editor-in-Chief
    Brandi M.L.
  2. The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome
    Cioppi F., Cianferotti L., Masi L., Giusti F., Brandi M.L.
  3. The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study
    Shafi Kuchay M., Kaur P., Sunil Kumar M., Mithal A.
  4. Histological study of atraumatic periprosthetic fractures: does atypical periprosthetic fracture exist?
    Bottai V., De Paola G., Celli F., Lazzerini I., Ortenzi V., Naccarato A.G., Guido G., Capanna R., Giannotti S.
  5. Enhanced bone healing and decreased pain in sacral insufficiency fractures after teriparatide treatment: retrospective clinical-based observational study
    Kasukawa Y., Miyakoshi N., Ebina T., Hongo M., Ishikawa Y., Kudo D., Nozaka K., Shimada Y.
  6. The effectiveness of intra-articular injections of Hyalubrix® combined with exercise therapy in the treatment of hip osteoarthritis
    Mauro G.L., Sanfilippo A., Scaturro D.
  7. Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study
    Leali P.T., Balsano M., Maestretti G., Brusoni M., Amorese V., Ciurlia E., Andreozzi M., Caggiari G., Doria C.
  8. Resistance exercise training restores bone mineral density in renal transplant recipients
    Eatemadololama A., Taghi Karimi M., Rahnama N., Hoseynen Rasolzadegan M.
  9. Clinical management of osteoporotic vertebral fracture treated with percutaneous vertebroplasty
    Capozzi A., Scambia G., Pedicelli A., Evangelista M., Sorge R., Lello S.
  10. Clinical-laboratory findings of bone metabolism in healthy premature and full-term neonates: preliminary results
    Dokos C., Tsakalidis C., Manaridou K., Manaridou K., Karayianni P., Kyrkos I., Roussos I.
  11. Anabolic treatment for osteoporosis: teriparatide
    Eastell R., Walsh J.S.
  12. Intra-articular therapy in hip osteoarthritis
    Migliore A., Anichini S.
  13. Hyaluronic acid vs corticosteroids in symptomatic knee osteoarthritis: a mini-review of the literature
    Bisicchia S., Tudisco C.
  14. Non-unions
    Calori G.M., Mazza E.L., Mazzola S., Colombo A., Giardina F., Romanò F., Colombo M.
  15. Periprosthetic fractures: epidemiology and current treatment
    Capone A., Congia S., Civinini R., Marongiu G.
  16. Orthopaedic procedures in haemophilia
    Rizzo A.R., Zago M., Carulli C., Innocenti M.
  17. Vitamin K and bone
    Fusaro M., Mereu M.C., Aghi A., Iervasi G., Gallieni M.
  18. Oral calcidiol is a good form of vitamin D supplementation
    Biondi P., Pepe J., Biamonte F., Occhiuto M., Parisi M., Demofonti C., Baffa V., Minisola S., Cipriani C.
  19. Oxidative stress in bone remodeling: role of antioxidants
    Domazetovic V., Marcucci G., Iantomasi T., Brandi M.L., Vincenzini M.T.
  20. Adipose stem cells for bone tissue repair
    Ciuffi S., Zonefrati R., Brandi M.L.
  21. Hypocalcemia and osteomalacia after bariatric surgery
    Ghazi A.A., Amirbaigloo A.
  22. Hypophosphatasia: clinical manifestation and burden of disease in adult patients
    Conti F., Ciullini L., Pugliese G.
  23. Nuclear magnetic resonance therapy (MBST) in the treatment of osteoporosis. Case report study
    Krpan D., Kullich W.
  24. Atypical presentation of spine bone metastasis in prostate cancer mimicking Pott’s disease
    Flais J., Coiffier G., Brillet E., Perdiger A., Guggenbuhl P.
  25. Infantile myofibromatosis of the iliac bone
    Rosello O., Rampal V., Doria C., Bertoncelli C., Clément J.-L., Solla F.
  26. Hypercalcemia, necrotizing pancreatitis and bone lesions: a benign cause
    Rauber C., Kihm L., Merle U.
  27. Primary central nervous system germinal center B-like diffuse large B-cell lymphoma: a case report
    Wang X.
  28. Two cases of Gorham-Stout disease with good response to zoledronic acid treatment
    Brance M.L., Castiglioni A., Cóccaro N., Palatnik M.
  29. Multiple fractures and impaired bone metabolism in Wolfram syndrome: a case report
    Catalano A., Bellone F., Cicala G., Giandalia A., Morabito N., Cucinotta D., Russo G.T.
  30. Spondylocarpotarsal synostosis syndrome. A rare case of short stature and congenital scoliosis
    Mangaraj S., Choudhury A.K., Singh M., Patro D., Baliarsinha A.K.
  31. Hydatid cyst in the vastus lateralis muscle: a case report
    Muratori F., De Gori M., D'Arienzo A., Bettini L., Roselli G., Campanacci D.A., Capanna R.
  32. Giant schwannoma of the foot: a case report and literature review
    Muratori F., De Gori M., Campo F.R., Bettini L., D'Arienzo A., Scoccianti G., Capanna R.
  33. Periostin and sclerostin levels in juvenile Paget’s disease
    Polyzos S.A., Makras P., Anastasilakis A.D., Mintziori G., Kita M., Papatheodorou A., Kokkoris P., Terpos E.
Last Viewed articles: la lista degli ultimi x visitati.
  1. The use of cholecalciferol in patients with hip fracture
    Cianferotti L., Parri S., Gronchi G., Civinini R., Brandi M.L.
    doi: 10.11138/ccmbm/2017.14.1.048
credits